blog-icon

Clinical research blog

Explore our blog for insights into the big questions in precision medicine and clinical research.

Clinical trial recruitment: Conversion and compliance

Most clinical trials fail to recruit enough participants on time. In rare disease and genetically stratified studies, the challenge is compounded: the patient p...
Continue reading

The importance of a patient-centric approach to patient recruitment

Patient recruitment efforts are often designed with the best of intentions, incorporating processes that fulfill every regulatory requirement. However, without ...
Continue reading

Key takeaways from an important conversation about IRD research

On October 18th, 2024 20/20 Onsite, Sano Genetics, and Clinical Enrollment announced the launch of a new partnership to offer a comprehensive solution for ident...
Continue reading

Rare disease drug development: Barriers and solutions

Rare disease drug development operates under a unique set of structural constraints. Patient populations are small and dispersed, diagnostic timelines are long,...
Continue reading

Technologies and tools enabling precision patient finding

There are a number of innovative tools and technologies which are enabling precision patient finding. From AI to e-consent, here we explore how they are changin...
Continue reading

How precision patient finding reduces research costs

Precision patient finding has the potential to radically reduce the cost of trials and create a more centralized approach which serves to benefit a multitude of...
Continue reading

Precision patient finding: the key to speed, savings, and trial success in biotech [whitepaper]

Clinical trials are essential for bringing new treatments to patients, but they’re not without challenges. Recruiting the right participants, staying on budget,...
Continue reading

What is precision patient finding?

Precision patient finding is an evolving field that is growing in line with the demands of precision medicine and rare disease research. Unlike traditional pati...
Continue reading

Neuron23 Unveils Groundbreaking Phase 2 Trial in Early Parkinson’s Disease

Sano is proud to support Neuron23 in the NEULARK Phase 2 clinical trial, a groundbreaking study exploring NEU-411, a brain-penetrant LRRK2 inhibitor with the po...
Continue reading

Inherited retinal disease: Mobile eye care partnership

A new partnership will bring together specialist eye care, genetic testing, and patient recruitment to advance both clinical research and care for people affect...
Continue reading